User Posts: admin3
0
FDA Speeds Up Review of Kidney Cancer CAR-T Cell Therapy
0

The FDA has granted a fast track designation for CAR-T cell therapy for certain patients with kidney cancer. The Food and Drug Administration (FDA) granted ...

0
Presurgical, Postsurgical Targeted Therapy Effective in Some Melanomas
0

Patients with stage 3 or 4 melanoma may benefit from receiving BRAF and MEK inhibitors if they are eligible for surgery. Presurgical and postsurgical ...

0
A winding road – the many adventures of a promising ADC – Cancer Research UK
0

Going viral “It turns out that many viruses when they infect your cells actually need the human host NMT to modify the virus protein. For example, in ...

0
13 Things I’ve Learned in 2 Years With 2 Cancer Types
0

What have I learned after two years with a diagnosis of renal clear cell carcinoma (kidney cancer) and advanced stage 4 pancreatic neuroendocrine tumors ...

0
Professor Edith Heard new Director of the Francis Crick Institute
0

‘An excellent scientist and leader’ Heard succeeds the Crick’s founding Director and Chief Executive, Sir Paul Nurse, who will continue to maintain a ...

0
Receiving Quality Support from Nurse Navigators During Breast Cancer
0

Receiving support from nurse navigators — even just to talk — allowed Ginger to think more positively during breast cancer. Diagnosed in 2011 with breast ...

0
Cancers caused by smoking reach all time high
0

The number of cancer cases caused by smoking in the UK has reached an all-time high of 160 cases every day, new analysis from Cancer Research UK shows.  ...

0
Breast cancer and smoking: What is the link?
0

Cancer is not a simple disease. A person’s risk of cancer can be affected by many things. These are known as risk factors and include things we can’t ...

0
Treatment Beyond Surgery for TGCT
0

Sydney Stern has undergone six surgeries for TGCT, or tenosynovial giant cell tumors. “So, we’ll say five too many, maybe,” she told CURE®.Stern, director ...

0
Explaining TGCT, the Rare Tumor Causing Pain and Limited Joint Mobility
0

There are not many patients with tenosynovial giant cell tumors, or TGCTs, with one expert telling CURE® that “about one in 1 million patients” will be ...

User Deals: admin3
Browsing All Comments By: admin3
CML Alliance
Logo
Enable registration in settings - general
Compare items
  • Total (0)
Compare
0
Shopping cart